Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 325

PDF Downloaded: 330


Get Permission Bansal, Bandhu, Sharma, Sandhu, and Kaur: Recurrent conjunctival papilloma: Case report


Introduction

Papilloma is a histopathological term describing specific morphology of tumors. Conjunctival papilloma is a benign growth that arises from the stratified squamous epithelium of the conjunctiva.1 They can be classified as pedunculated or sessile. The pedunculated type is synonymous with infectious conjunctival papilloma and squamous cell papilloma. The sessile type is synonymous with limbal conjunctival papilloma as they are believed to arise from UV radiation exposure and are non infectious. A strong association exists between development of conjunctival papilloma and human papilloma virus (HPV) types 6 and 11.2 These are known to occur both in children and adults with the highest incidence between 21 and 40 years and there is a male preponderance.3, 4 The most common sites for conjunctival papilloma are bulbar conjunctiva,5 palpebral conjunctiva3 and caruncle.4, 6

Case Report

Case 1

A 60-year-old male presented with recurrent limbal conjunctival swelling in left eye. He had history of gradually increasing conjunctival swelling since six months. Patient gave history of excision of similar swelling at the same location 9 months back. The failure of first excision biopsy done 9 months back could be due to high recurrence rate of upto 27% seen in conjunctival papillomas. The patient did not have any major symptoms except for mild discomfort but he reported gradual increase in size of swelling. On examination, the swelling was present inferiorly from 5 to 8 o` clock position at limbus. The swelling was sessile and was encroaching towards cornea (Figure 1).

Figure 1

Pre operative image of conjunctival papilloma (case 1)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/be880bfd-0546-406a-ab12-8d19d77e3163-uimage.png

Case 2

A 70-year-old male presented with complaints of diminution of vision, watering, forgien body sensation, photophobia and blepahrospasm. The patient had history of gradually increasing conjunctival growth since 9 months. The patient gave history of excision of similar swelling one and a half year back. On examination, his visual acuity was hand movements, conjunctival growth covering 270 degree of limbal area and extending over whole of the cornea was noticed (Figure 2).

Figure 2

Pre operative image of growth with both conjunctival and corneal involvement (case 2)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/af3fe884-3cc4-4614-8615-06d7f21e8275-uimage.png

Excisional biopsy of the swelling was performed under local anaesthesia. Excision was done with aim of clearing 1mm of normal conjunctival tissue. The swelling was found to be growing onto the cornea at the limbus. Limbal area was cleared with use of diamond burr. Double freeze thaw method of cryotherapy was applied at the base of remaining conjunctival tissue (Figure 3). Mitomycin C (0.3 mg/ ml) was applied to the base of the growth for 3 minutes (Figure 4). This was followed by copious irrigation and application of cryotherapy. The excised tissue was sent for histopathological examination which confirmed the diagnosis of benign conjunctival papilloma and confirmed marginal clearance of excised tissue. (Figure 5). Patient was started post operatively on chloramphenicol eye drops and mitomycin C eye drops (0.002%) for a period of 3 months to prevent recurrence.(Figure 6)

Figure 3

Intraoperative application of cryotherapy

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/11ab1bde-8958-4ec8-8ed3-9f940f7aaae9-uimage.png

Figure 4

Intraoperative application of Mitomycin C

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/1abfb061-723c-4590-aa05-2245c65e2ee3-uimage.png

Figure 5

Histopathology report

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/5a9fb454-0588-41db-a4c0-ae81a6179643-uimage.png

Both the patients were followed over a period of two years. The patient in case 2 had remarkable improvement in symptoms and his visual acuity improved to 6/18 (Figure 7). There were no signs of recurrence of lesion. Both the patients are still being followed up for recurrence of lesions.(Figure 8 )

Figure 6

Immediate post operative image (case 2)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/ca7584e9-679e-4a1f-a0f2-5104b4ac1b0f-uimage.png

Figure 7

6 months post-operative (case 2)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/0c6d5ed4-a3d6-4e83-91d4-6d84b1d040c3-uimage.png

Figure 8

Post-operative image (case 1)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/bcb3c4d1-c8df-4021-a710-e0370d514817/image/59d2e5b9-dff3-4b2e-9ff7-32ce7d1c8a9b-uimage.png

Discussion

The recurrence rates of conjunctival papilloma has been reported to range from 3% to 27%.4, 5, 6 Various adjunctive therapeutic modalities have been described to prevent recurrence such as CO2 laser, adjunctive cryotherapy, topical mitomycin C or interferon alpha 2b and post-operative use of oral cimetidine.3, 4, 7, 8, 9, 10, 11, 12, 13 Conservative treatment involves observation and reassuring the patient as lesions may regress spontaneously.14 Regression of the lesion was observed after use of topical interferon alpha 2b in small to medium lesions.15, 16 Cryotherapy is used as adjunctive therapy especially in recurrent lesions. Double freeze thaw method is preferred and it causes minimal scarring. Use of topical antimetabolites like Mitomycin C and 5 Flurouracil has been reported to prevent recurrence. Co2 laser has been found to be safe and effective. Dinitrochlorobenzene (DNCB) is reserved for cases where other treatment modalities as surgical excision and cryoablation have failed.14, 17

Conclusion

Conjunctival papillomas are benign tumours with a minimal propensity toward malignancy. The risk is malignant transformation is noticed especially in papillomas with inverted growth pattern or reccurence.18 Long term surveillance is required in these patients.

Source of Funding

None.

Conflict of Interest

None.

References

1 

S Farah TD Baum MR Conlon EC Alfonso T Starck Tumours of the cornea and conjunctivaPrinciples and Practice of Ophthalmology2nd edW.B SaundersPennsylvania200010021021

2 

NC Sjö, CV Buchwald P Cassonnet B Norrild JU Prause T Vinding Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: Types and frequencies in a large seriesBr J Ophthalmol200791810145

3 

N Sjö S Heegaard JU Prause Conjunctival papilloma. A histopathologically based retrospective studyActa Ophthalmol Scand20007866636

4 

S Kaliki S Arepalli CL Shields K Klein H Sun E Hysenj Conjunctival papilloma: Features and outcomes based on age at initial examinationJAMA Ophthalmol2013131558593

5 

JE Ash Epibulbar tumorsAm J Ophthalmol195033120319

6 

YM Huang YY Huang HY Yang CC Tsai WK Yu SC Kao Conjunctival papilloma: Clinical features, outcome, and factors related to recurrenceTaiwan J Ophthalmol201881158

7 

JM Omohundro JH Elliott Cryotherapy of conjunctival papillomaArch Ophthalmol19708460910

8 

KE Morgenstern J Givan LA Wiley Long-term administration of topical interferon alfa-2beta in the treatment of conjunctival squamous papillomaArch Ophthalmol2003121710523

9 

LA Falco PJ Gruosso K Skolnick L Bejar Carbon dioxide laser therapy of recurrent squamous papilloma of the conjunctivaOphthalmic Surg198213119168

10 

B Jean HJ Thiel K Stumper CO2 laser vaporization of papilloma of the conjunctiva and eyelidsFortschr Ophthalmol1989866725

11 

HK Yuen EF Yeung NR Chan SC Chi DS Lam The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papillomaCornea20022188389

12 

SW Chang ZL Huang Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosisCornea200625668790

13 

CS Slade NN Katz PV Whitmore DS Bardenstein Conjunctival and canalicular papillomas and ichthyosis vulgarisAnn Ophthalmol19882072515

14 

BA Schechter WJ Rand GE Velazquez WD Williams L Starasoler Treatment of conjunctival papillomata with topical interferon Alfa-2bAm J Ophthalmol2002134226870

15 

De Keizer Rj W De Wolff-Rouendaal Topical a-interferon in Recurrent Conjunctival PapillomaActa Ophthalmologica Scandinavica2003193196

16 

R Petrelli E Cotlier S Robins K Stoessel Dinitrochlorobenzene immunotherapy of recurrent squamous papilloma of the conjunctivaOphthalmology1981881212215

17 

S Lassalle C Maschi JP Caujolle V Giordanengo P Hofman Inverted conjunctival papilloma: A certainly underestimated high-risk lesion for carcinomatous transformation-a case reportCan J Ophthalmol2017521301

18 

L Bredow G Martin T Reinhard H Mittelviefhaus C Auw-Haedrich Recurrent conjunctival papilloma progressing into squamous cell carcinoma with change of HPV-finding during the courseBr J Ophthalmol20099311143751



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Case Report


Article page

196-199


Authors Details

Yashi Bansal*, Seema Dutt Bandhu, Umesh Sharma, Harkirat Kaur Sandhu, Samreen Kaur


Article History

Received : 05-09-2023

Accepted : 09-12-2023


Article Metrics


View Article As

 


Downlaod Files